FAQ
Log In
Sunday 20th May 2018
News
 › 
 › 

Diabetes drug may increase bladder cancer risk

1st June 2012

A study based on NHS records has found that a drug used to control Type 2 diabetes could double the risk of bladder cancer.

Writing online in the British Medical Journal, the researchers from the Jewish General Hospital in Montreal, found that pioglitazone, which is taken by about 20,000 people and used to control blood sugar levels, increased the risk while the comparable drug rosiglitazone did not. Around 10,000 people are diagnosed with bladder cancer every year and almost 5,000 die of it.

 

Share this page

Comments

carol zhu

Thursday 14th June 2012 @ 20:41

According to another new study, it might also cause macular edema, which is the most common cause of blindness in adults


Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Article Information

Title: Diabetes drug may increase bladder cancer risk
Author: Mark Nicholls
Article Id: 22051
Date Added: 1st Jun 2012

Sources

The Telegraph

Recent Related Articles

Vegetables could lower risk of Alzheimer's

Actions

Add to scrapbook
Show Comments
Add comment
Find all related articles

Tags

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2018